Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A structural explanation for ERalpha/ERbeta SERM discrimination.

G L Greene1, A K Shiau, K W Nettles

  • 1Ben May Institute for Cancer Research, Department of Biochemistry and Molecular Biology, The University of Chicago, IL 60637, USA. ggreene@uchicago.edu

Ernst Schering Research Foundation Workshop
|July 14, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unconventional isoquinoline-based SERMs elicit fulvestrant-like transcriptional programs in ER+ breast cancer cells.

NPJ breast cancer·2022
Same author

Conference Reports: THE INVESTIGATION OF FUNDAMENTAL INTERACTIONS WITH COLD NEUTRONS.

Journal of research of the National Bureau of Standards (1977)·2021
Same author

First Precision Measurement of the Parity Violating Asymmetry in Cold Neutron Capture on ^{3}He.

Physical review letters·2020
Same author

Structure of LRRK2 in Parkinson's disease and model for microtubule interaction.

Nature·2020
Same author

Imaging Fluorescence of He_{2}^{*} Excimers Created by Neutron Capture in Liquid Helium II.

Physical review letters·2020
Same author

Precision determination of absolute neutron flux.

Metrologia·2019
Same journal

Stem cells in reproduction and in the brain. Proceedings of a workshop. September 1-3, 2005. Kobe, Japan.

Ernst Schering Research Foundation workshop·2007
Same journal

Can cell systems biology rescue drug discovery?

Ernst Schering Research Foundation workshop·2007
Same journal

Applying a causal framework to system modeling.

Ernst Schering Research Foundation workshop·2007
Same journal

A plea for more theory in molecular biology.

Ernst Schering Research Foundation workshop·2007
Same journal

Network genomics.

Ernst Schering Research Foundation workshop·2007
Same journal

The theory of biological robustness and its implication in cancer.

Ernst Schering Research Foundation workshop·2007
See all related articles

Researchers discovered a new passive antagonism mechanism for nuclear receptors (NRs). This finding enables designing compounds that selectively target specific NR subtypes, potentially leading to novel therapeutic effects.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Nuclear Receptors (NRs) often exhibit multiple subtypes with unique expression patterns and target genes.
  • Current NR antagonists, created by adding bulky side chains to agonists, typically act on one or more subtypes of a specific NR.

Purpose of the Study:

  • To explore a novel mechanism for achieving nuclear receptor antagonism.
  • To investigate the potential for designing selective NR subtype modulators.

Main Methods:

  • Direct comparison of two THC-ER Ligand Binding Domain (LBD) complexes.
  • Structural analysis to reveal the passive antagonism mechanism.

Main Results:

  • A passive antagonism mechanism for NRs was identified.

Related Experiment Videos

  • This mechanism allows for selective stabilization of inactive or active conformations of different NR subtypes.

    • Conclusions:

    • The identified passive antagonism mechanism offers a new strategy for NR antagonist design.
    • Selective NR subtype modulation through designed ligands could yield novel biological and therapeutic outcomes.